MTLS Earnings Date: Feb 18, 2027 (Estimated) — Materialise N.V.
NASDAQ · Technology · Software - Application
Updated
When is MTLS's next earnings date?
Materialise N.V. (MTLS) is expected to report Q4 2026 earnings on Thursday, February 18, 2027 at 1:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company.
How did MTLS do in its last earnings report?
In its most recent report on Oct 28, 2026 (Q3 2026), Materialise N.V. posted EPS of $0.03 versus the $0.05 estimate, a miss of 34.3%. Revenue was $80.0M against a $78.2M estimate. The stock's 1-day post-earnings move was -21.3%.
How much does MTLS stock move after earnings?
MTLS beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 14.6% (up or down) in the day after earnings.
About Materialise N.V.
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
🤖 AI Earnings Analysis
Materialise’s Q3 was mixed: revenue of $80M beat estimates by $2M, but EPS of $0.03 missed by $0.02 and slipped from $0.04 year over year. Its $318M–$329M revenue outlook offers a path to recovery, but weak profitability tempers confidence in this 3D-printing software and medical-device business.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | Q3 2026 | 0.05 | 0.03 | -34.33% | $80.0M | ❌ Miss | -21.35% | — | — |
| 2026-08-27 | Q2 2026 | 0.05 | 0.07 | +75.00% | $79.8M | ✅ Beat | +11.24% | +6.00% | +26.39% |
| 2026-05-07 | Q1 2026 | 0.01 | 0.04 | +300.00% | $76.2M | ✅ Beat | -3.20% | -0.53% | +16.73% |
| 2026-02-19 | Q4 2025 | 0.01 | 0.12 | +1100.00% | $82.4M | ✅ Beat | +9.44% | -2.22% | -7.41% |
| 2025-10-28 | Q3 2025 | 0.01 | 0.04 | +300.00% | $77.8M | ✅ Beat | -4.04% | +11.11% | +2.36% |
| 2025-04-24 | Q1 2025 | -0.04 | -0.01 | +75.00% | $71.8M | ✅ Beat | +14.25% | +11.02% | +10.37% |
| 2025-02-20 | Q4 2024 | 0.05 | 0.05 | +0.00% | $68.2M | ➖ Inline | -35.36% | -41.49% | -44.58% |
| 2024-10-24 | Q3 2024 | 0.03 | 0.06 | +100.00% | $76.9M | ✅ Beat | +18.27% | +21.22% | +46.95% |
Showing last 8 quarters.
Revenue by segment & region
By region
FY2025 · $220.5M total · annual
| Segment | Share | Revenue | YoY | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 50.3% | $110.9M | +2.1% | — | $69.1M | $79.4M | $90.3M |
| GERMANY | 14.0% | $30.9M | -11.7% | — | — | — | — |
| SWITZERLAND | 9.3% | $20.5M | +3.8% | — | $13.6M | $16.9M | $20.8M |
| Asia Pacific | 8.8% | $19.3M | +6.9% | — | $19.5M | $20.0M | $20.0M |
| FRANCE | 7.8% | $17.2M | -0.9% | — | $13.0M | $16.2M | $19.1M |
| ITALY | 3.7% | $8.2M | -2.8% | — | $6.5M | $8.1M | $11.4M |
| NETHERLANDS | 3.4% | $7.5M | -5.9% | — | $7.3M | $6.6M | $8.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.